Pediatric Psoriasis: Infection Risk Low With Systemic Meds

The results are from a large cohort study that estimated the 6-month rate of infections among children with psoriasis who started treatment with ustekinumab, etanercept, or methotrexate.
MDedge News

source https://www.medscape.com/viewarticle/988361?src=rss

Comments

Popular posts from this blog

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?